| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 266,658 | 225,192 | 228,367 | 283,229 | | Cost of Revenue | 169,529 | 149,464 | 157,267 | 207,231 | | | Gross Profit | 97,129 | 75,728 | 71,100 | 75,998 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 108,192 | 82,761 | 82,712 | 110,299 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (11,063) | (7,033) | (11,612) | (34,301) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| 190 | 130 | 230 | | Earnings Before Interest And Taxes | (11,941) | (6,843) | (11,482) | (34,071) | | Interest Expense | (630) | 341 | 289 | 165 | | Income Before Tax | (11,311) | (7,184) | (11,771) | (34,236) | | Income Tax Expense | 22,659 | (2,262) | (4,209) | (15,683) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (33,970) | (4,922) | (7,562) | (18,553) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (33,970) | (4,922) | (7,562) | (18,553) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($33,970) | ($4,922) | ($7,562) | ($18,553) |
|
1.52% Nasdaq 0.00%
Income Statement
